2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2014 Symposium

2013 Featured Talks

Previous Symposia

2017 Featured Talks » RON kinase as a Modulator of the Pancreatic Cancer Microenvironment

RON kinase as a Modulator of the Pancreatic Cancer Microenvironment

Andrew Lowy, MD, FACS
UC San Diego Moores Cancer Center

Part 1

Part 2

Andrew Lowy, MD, FACS
Chief, Division of Surgical Oncology
Professor of Surgery
UC San Diego Moores Cancer Center

Andrew M. Lowy, MD is a surgical oncologist with a primary interest and expertise in pancreatic cancer treatment and research. Dr. Lowy serves chair of the National Cancer Institute’s Pancreatic Cancer Task Force which is charged with setting the direction of clinical research in pancreatic cancer in the United States. He also serves as surgical liaison to the Pancreas sub-committee of the Southwest Oncology Group (SWOG), and as the surgical principal investigator for the largest adjuvant pancreatic cancer clinical trial ever conducted in the United States. Dr. Lowy's laboratory focuses on the study of pancreatic cancer signaling and preclinical modeling and his lab co-developed the first genetically engineered mouse model of pancreatic cancer currently used in laboratories worldwide. His lab has been continuously funded by the National institutes of Health/National Cancer Institute to study pancreatic cancer since 1999. He is also currently funded as part of the first Stand-Up-To –Cancer TransAtlantic Pancreatic Cancer Dream Team.